Intel says new transistor technology could boost chip performance 20% - Reuters
(Reuters) - Intel Corp ( INTC.O ) on Thursday disclosed a new method for making transistors on semiconductors that its chief architect said could boost the performance Intel’s next round of processors by as much as 20%.
Biden says all U.S. governors should mandate masks to slow pandemic - Reuters
WILMINGTON, Del. (Reuters) - Democratic presidential contender Joe Biden on Thursday called on all U.S. governors to mandate mask wearing to slow the spread of the coronavirus that has killed more than 165,000 people in the United States.
In his second day on the campaign trail with former rival and now running mate Kamala Harris by his side, Biden made the call for a nationwide mandate on masks after a virtual meeting with public health advisers in his hometown of Wilmington, Delaware.
“
Biden says all U.S. governors should mandate masks to slow pandemic - Reuters
WILMINGTON, Del. (Reuters) - Democratic presidential contender Joe Biden on Thursday called on all U.S. governors to mandate mask wearing to slow the spread of the coronavirus that has killed more than 165,000 people in the United States.
In his second day on the campaign trail with former rival and now running mate Kamala Harris by his side, Biden made the call for a nationwide mandate on masks after a virtual meeting with public health advisers in his hometown of Wilmington, Delaware.
“
European battery makers power up for a green recovery - Reuters
August 13 (Reuters) - European battery makers are gearing up to take advantage of massive “green” stimulus packages unveiled since the coronavirus pandemic though many acknowledge it will be tough to match the Asian giants that dominate the mainstream market.
While Sweden’s Northvolt, and more recently France’s Verkor, are making a play for large-scale production,
Exclusive: Trump administration asks court to dismiss Big Tech's challenge to social media executive order - Reuters
WASHINGTON (Reuters) - The Trump administration has filed a motion asking a court to dismiss a lawsuit against the president’s executive order targeting social media companies, calling it a “profound misunderstanding,” according to a copy of the motion seen by Reuters.
The lawsuit was brought in June by the Center for Democracy and Technology (CDT), a Washington-based tech group funded by Facebook Inc
Lyft maintains end-2021 profitability goal even as COVID-19 guts demand - Reuters
(Reuters) - Lyft Inc said on Wednesday cost cuts put the company on track to reach its goal of becoming profitable on an adjusted basis by the end of 2021, even as its second-quarter revenue tumbled 61% due to coronavirus-related restrictions.
On a post-earnings call, executives said the company would be
Airbnb's quarterly revenue slumps; 2020 IPO plans still on: Bloomberg News - Reuters
(Reuters) - Short-term home rental company Airbnb Inc’s quarterly revenue plunged 67% as fewer people traveled due to the COVID-19 pandemic, but its plans for a stock market debut before year’s end are still on, Bloomberg reported, citing people familiar with the matter.
Revenue fell to $335 million in
Sarah Cooper, TikTok star who lip syncs to Trump, lands Netflix comedy special - Reuters
LOS ANGELES (Reuters) - Comedian Sarah Cooper, who became a TikTok sensation with satirical videos of President Donald Trump, will appear in her own variety special on Netflix, the streaming service announced on Wednesday.
“Sarah Cooper: Everything’s Fine” will feature vignettes on politics, race, gender, class, “and other light subjects,” Netflix said in a statement. Set to air in the fall, the special also will feature guests taking part in interviews and sketches.
Cooper, 42, became
Brazil's Parana state agrees to produce Russian COVID-19 vaccine - Reuters
BRASILIA, Aug 12 (Reuters) - The Brazilian state of Parana on Wednesday reached an agreement with Russia to produce a COVID-19 vaccine that Moscow has touted as ready to be brought to market, the state’s press office said.
The Russian vaccine has grabbed headlines for going to market while other pharmaceutical companies are still carrying out mass testing. (Reporting by Anthony Boadle Writing by Marcelo Rochabrun Editing by Brad Haynes)